Drug Profile
ALTU 140
Alternative Names: ALTU-140Latest Information Update: 05 Sep 2006
Price :
$50
*
At a glance
- Originator Altus Pharmaceuticals
- Class Analgesics
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Mar 2006 Discontinued - Preclinical for Pain in USA (PO)
- 25 May 2004 Altus Biologics is now called Altus Pharmaceuticals
- 05 Feb 2004 Preclinical trials in Pain in USA (PO)